Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.
Fedele C, Riccio G, Coppola C, Barbieri A, Monti MG, Arra C, Tocchetti CG, D'Alessio G, Maurea N, De Lorenzo C. Fedele C, et al. Among authors: de lorenzo c. Breast Cancer Res Treat. 2012 Jun;133(2):511-21. doi: 10.1007/s10549-011-1783-9. Epub 2011 Sep 27. Breast Cancer Res Treat. 2012. PMID: 21947749
Effects of a human compact anti-ErbB2 antibody on prostate cancer.
Malara AE, Fedele C, Aloj L, Arra C, Laccetti P, D'Alessio G, De Lorenzo C. Malara AE, et al. Among authors: de lorenzo c. Oncol Rep. 2012 Jul;28(1):297-302. doi: 10.3892/or.2012.1760. Epub 2012 Apr 10. Oncol Rep. 2012. PMID: 22505344
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.
Tocchetti CG, Carpi A, Coppola C, Quintavalle C, Rea D, Campesan M, Arcari A, Piscopo G, Cipresso C, Monti MG, De Lorenzo C, Arra C, Condorelli G, Di Lisa F, Maurea N. Tocchetti CG, et al. Among authors: de lorenzo c. Eur J Heart Fail. 2014 Apr;16(4):358-66. doi: 10.1002/ejhf.50. Eur J Heart Fail. 2014. PMID: 24464789 Free article.
Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, Esposito E, De Lorenzo C, De Laurentiis M, Spallarossa P, Mercuro G. Maurea N, et al. Among authors: de lorenzo c, de laurentiis m. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S19-26. doi: 10.2459/JCM.0000000000000377. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183521 Review.
Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, Esposito E, De Lorenzo C, De Laurentiis M, Spallarossa P, Mercuro G. Maurea N, et al. Among authors: de lorenzo c, de laurentiis m. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e19-e26. doi: 10.2459/JCM.0000000000000377. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755239 Review.
233 results